E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 

Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each.


Click on the deal summary to see the full details.

Gilead Sciences Inc. 5.250% due 10/15/2033

Gilead Sciences Inc. 5.550% due 10/15/2053

Gilead Sciences Inc. L+15 due 9/17/2021

Gilead Sciences Inc. L+52 due 9/29/2023

Gilead Sciences Inc. 0.750% due 9/29/2023

Gilead Sciences Inc. 1.200% due 10/1/2027

Gilead Sciences Inc. 1.650% due 10/1/2030

Gilead Sciences Inc. 2.600% due 10/1/2040

Gilead Sciences Inc. 2.800% due 10/1/2050

Gilead Sciences Inc. 1.850% due 9/20/2019

Gilead Sciences Inc. L+17 due 9/20/2018

Gilead Sciences Inc. L+22 due 3/20/2019

Gilead Sciences Inc. L+25 due 9/20/2019

Gilead Sciences Inc. 1.950% due 3/1/2022

Gilead Sciences Inc. 2.500% due 9/1/2023

Gilead Sciences Inc. 2.950% due 3/1/2027

Gilead Sciences Inc. 4.000% due 9/1/2036

Gilead Sciences Inc. 4.150% due 3/1/2047

Gilead Sciences Inc. 1.850% due 9/4/2018

Gilead Sciences Inc. 2.550% due 9/1/2020

Gilead Sciences Inc. 3.250% due 9/1/2022

Gilead Sciences Inc. 3.650% due 3/1/2026

Gilead Sciences Inc. 4.600% due 9/1/2035

Gilead Sciences Inc. 4.750% due 3/1/2046

Gilead Sciences Inc. 2.350% due 2/1/2020

Gilead Sciences Inc. 3.500% due 2/1/2025

Gilead Sciences Inc. 4.500% due 2/1/2045

Gilead Sciences Inc. 2.050% due 4/1/2019

Gilead Sciences Inc. 3.700% due 4/1/2024

Gilead Sciences Inc. 4.800% due 4/1/2044

Gilead Sciences, Inc. 2.400% due 12/1/2014

Gilead Sciences, Inc. 3.050% due 12/1/2016

Gilead Sciences, Inc. 4.400% due 12/1/2021

Gilead Sciences, Inc. 5.650% due 12/1/2041

Gilead Sciences, Inc. 4.500% due 4/1/2021



© 2012 Prospect News.
All content in this database is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.